A Novel Long-Acting Azathioprine Polyhydroxyalkanoate Nanoparticle Enhances Treatment Efficacy for Systemic Lupus Erythematosus with Reduced Side Effects.

Jin Hu,Min Wang,Xinyue Xiao,Bo Zhang,Qiu Xie,Xinjie Xu,Shengjie Li,Zhifa Zheng,Daixu Wei,Xuan Zhang
DOI: https://doi.org/10.1039/d0nr01308k
IF: 6.7
2020-01-01
Nanoscale
Abstract:A polyhydroxyalkanoate terpolymer based drug delivery platform loaded with immunosuppressant for systemic lupus erythematosus therapy with less systemic toxicity.
What problem does this paper attempt to address?